Skip to main content
Log in

Is population-based screening for foetal CMV infections cost effective in France?

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Seror V, et al. Leaning towards Cytomegalovirus serological screening in pregnancy to prevent congenital infection: a cost-effectiveness perspective. BJOG: An International Journal of Obstetrics and Gynaecology : 15 Oct 2021. Available from: URL: http://doi.org/10.1111/1471-0528.16966

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Is population-based screening for foetal CMV infections cost effective in France?. PharmacoEcon Outcomes News 890, 13 (2021). https://doi.org/10.1007/s40274-021-08136-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-08136-z

Navigation